ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,301Medicare Part D Prescriptions Filled, Including Refills

Rank: 194 out of 1454

$576K Total Retail Price of All Prescriptions

Rank: 345 out of 1454

522 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 522 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 522 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,627 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 470 452 1 3
FUROSEMIDE 421 413 2 6
LEVOTHYROXINE SODIUM 414 400 3 5
CITALOPRAM HBR 336 311 4 21
DONEPEZIL HCL 329 329 5 29
WARFARIN SODIUM 316 316 6 17
AMLODIPINE BESYLATE 302 292 7 2
PRAVASTATIN SODIUM 287 265 8 12
METOPROLOL TARTRATE 286 274 9 10
LISINOPRIL 272 246 10 4
METFORMIN HCL 270 237 11 8
POLYETHYLENE GLYCOL 3350 265 259 12 61
TRAMADOL HCL 264 262 13 20
GABAPENTIN 259 229 14 16
METOPROLOL SUCCINATE 252 251 15 13
TRAZODONE HCL 248 228 16 50
HYDROCODONE-ACETAMINOPHEN 243 228 S3 17 7
NAMENDA 208 208 18 48
TRIAMTERENE-HCTZ 171 162 19 44
SERTRALINE HCL 170 169 20 26
LOSARTAN POTASSIUM 166 166 21 14
TAMSULOSIN HCL 156 154 22 34
MIRTAZAPINE 153 136 23 53
ATENOLOL 148 141 24 18
SIMVASTATIN 142 138 25 1
RISPERIDONE 136 136 26 86
ATORVASTATIN CALCIUM 129 127 27 11
PANTOPRAZOLE SODIUM 120 103 28 31
POTASSIUM CHLORIDE 120 110 28 15
LOSARTAN-HYDROCHLOROTHIAZIDE 118 99 30 38
PAROXETINE HCL 118 111 30 73
HYDROCHLOROTHIAZIDE 113 112 32 9
FLUOXETINE HCL 108 101 33 72
FLUTICASONE PROPIONATE 107 95 34 30
LANTUS 99 89 35 51
ALLOPURINOL 94 92 36 28
GLIPIZIDE 93 70 37 62
ZOLPIDEM TARTRATE 92 92 38 19
RANITIDINE HCL 88 88 39 43
CARBIDOPA-LEVODOPA 88 88 39 130
FENTANYL 88 88 S2 39 104
GLIPIZIDE ER 84 84 42 92
DIGOXIN 73 73 43 70
BENAZEPRIL HCL 73 73 43 57
LIDODERM 68 68 45 158
GLIPIZIDE XL 68 68 45 85
MELOXICAM 66 51 47 37
SPIRIVA 65 65 48 52
BUSPIRONE HCL 65 65 48 176
CARVEDILOL 62 56 50 24
FINASTERIDE 62 62 50 94
VENLAFAXINE HCL ER 62 62 50 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 56 53 27
CEPHALEXIN 57 55 54 127
COLCRYS 56 49 55 116
LOVASTATIN 55 43 56 39
AMIODARONE HCL 54 54 57 223
ISOSORBIDE MONONITRATE ER 53 53 58 46
GLIMEPIRIDE 53 41 58 33
SYNTHROID 50 50 60 25
PROAIR HFA 50 43 60 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.